Logo image
Se connecter
Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301)
Article de revue   Avec comité de lecture

Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301)

M. Ychou, W. Hohenberger, S. Thezenas, M. Navarro, P. Gascon, C. Bokemeyer, E. Shacham-Shmueli, F. Rivera, C. Kwok-Keung Choi et A. Santoro
Journal of clinical oncology, Vol.26(15_suppl), pp.LBA4013-LBA4013
20/05/2008

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Logo image